Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1997-03-04
1998-09-22
Grumbling, Matthew V.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514339, 514365, 548181, 5462704, 544253, C07D40306, C07D40314, A61K 31495, A61K 3144
Patent
active
058114254
ABSTRACT:
The present invention relates to COX-2 inhibitors of the formula: ##STR1## wherein, A=halogen, C.sub.1 -C.sub.6 alkyl, SR.sup.1 or OR.sup.1 ;
REFERENCES:
patent: 3749731 (1973-07-01), Zinnes et al.
patent: 3752893 (1973-08-01), Roscoe et al.
patent: 4002749 (1977-01-01), Rovnyak
patent: 4391814 (1983-07-01), Vorbruggen
patent: 4618617 (1986-10-01), Yamamoto
patent: 4963689 (1990-10-01), Nagel et al.
patent: 5143927 (1992-09-01), Boschelli et al.
patent: 5484940 (1996-01-01), Grant et al.
Chiarino et al; Synthesis and In Solution Behaviour of New 2-Substituted-4-Thiazolidinecarboxylic Acid Derivatives; J. Heterocyclic Chem., 26, 589 (1989).
McCroskey Richard W.
Michaelides Michael R.
Woods Keith W.
Abbott Laboratories
Grumbling Matthew V.
Pope Lawrence S.
LandOfFree
Heterocyclic compounds as COX-2 inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Heterocyclic compounds as COX-2 inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterocyclic compounds as COX-2 inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1622002